Coronavirus Update: Rapid Restart For AZ’s Vaccine Trial, Pfizer Upsizes Its Phase III

UK Regulator Gives Green Light

Clearance by UK regulator allows trial to restart, with pivotal US trial hoped to follow suit to keep AstraZeneca and Oxford's candidate on track for a potential late 2020 readout. Plus, new results with Sinovac's vaccine in the elderly and progress with antibodies.  

Covid19_Carpark
The UK regulator's clearance has allowed the trial to restart, its counterparts in the US, South Africa and Brazil expected to follow suit. • Source: Shutterstock

AstraZeneca PLC and Oxford University have been given the green light to restart their coronavirus vaccine trial in the UK, following a safety review.

The partners can now re-commence the trial of AZD1222 following confirmation by the Medicines Health Regulatory Authority (MHRA), and announced...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip